These novel therapies , Tirzepatide , represent a groundbreaking advancement in managing type 2 diabetes and potentially related conditions . They are classified as GLP-1 receptor agonists , indicating https://abelctdf033898.blogspothub.com/40139551/tirzepatide-a-comprehensive-examination-into-metabolic-agents